Market closedNon-fractional
Kezar Life Sciences/KZR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Kezar Life Sciences
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Ticker
KZR
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
South San Francisco, United States
Employees
58
Website
www.kezarlifesciences.com
KZR Metrics
BasicAdvanced
$42M
Market cap
-
P/E ratio
-$1.39
EPS
0.22
Beta
-
Dividend rate
Price and volume
Market cap
$42M
Beta
0.22
Financial strength
Current ratio
11.485
Quick ratio
11.314
Long term debt to equity
8.188
Total debt to equity
10.812
Interest coverage (TTM)
-66.09%
Management effectiveness
Return on assets (TTM)
-27.01%
Return on equity (TTM)
-48.07%
Valuation
Price to revenue (TTM)
6.012
Price to book
0.25
Price to tangible book (TTM)
0.25
Price to free cash flow (TTM)
-0.494
Growth
Earnings per share change (TTM)
31.32%
3-year earnings per share growth
14.82%
What the Analysts think about KZR
Analyst Ratings
Majority rating from 6 analysts.
KZR Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$0
-100.00%
Net income
-$32M
39.39%
Profit margin
0.00%
-100.00%
KZR Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.34
-$0.32
-$0.44
-$0.30
-
Expected
-$0.32
-$0.35
-$0.38
-$0.33
-$0.32
Surprise
6.25%
-8.35%
15.85%
-9.86%
-
KZR News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kezar Life Sciences stock?
Kezar Life Sciences (KZR) has a market cap of $42M as of July 06, 2024.
What is the P/E ratio for Kezar Life Sciences stock?
The price to earnings (P/E) ratio for Kezar Life Sciences (KZR) stock is 0 as of July 06, 2024.
Does Kezar Life Sciences stock pay dividends?
No, Kezar Life Sciences (KZR) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Kezar Life Sciences dividend payment date?
Kezar Life Sciences (KZR) stock does not pay dividends to its shareholders.
What is the beta indicator for Kezar Life Sciences?
Kezar Life Sciences (KZR) has a beta rating of 0.22. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
![Buy or sell Kezar Life Sciences stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell Kezar Life Sciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.